Recombinant Fowlpox-PSA(L155)/TRICOM Vaccine
Semantic Scholar uses AI to extract papers important to this topic.
Vaccine approaches for cancer differ from traditional vaccine approaches for infectious disease in tending to focus on clearing… Expand Significance Because individual cancer patients differ considerably in their clinical benefits from immunotherapies, early… Expand Opinion statementAt present, sipuleucel-T represents the only approved immunotherapy for prostate cancer. Sipuleucel-T is an… Expand Since the approval of sipuleucel-T for men with metastatic castrate resistant prostate cancer in 2010, great strides in the… Expand Purpose: There is evidence that therapeutic cancer vaccines can lengthen survival for some patients with cancer, but responses… Expand CONTEXT
The first therapeutic cancer vaccine demonstrating effectiveness in a phase 3 study was approved by the US Food and Drug… Expand The interaction between the immune system and prostate cancer has been an area of research interest for several decades. The… Expand Prostvac is a prostate cancer vaccine regimen consisting of a recombinant vaccinia vector as a primary vaccination, followed by… Expand PurposeBased on previous studies that demonstrated the safety profile and preliminary clinical activity of prostate specific… Expand 2504 Background: Vaccine strategies represent a novel therapeutic approach for the treatment of metastatic AIPC. Preclinical and… Expand